We further demonstrated that PEG significantly reduced the expression of Cyclin D1, a downstream effector of EGFR that is overexpressed in HNSCC [21] and involved in causing resistance to therapeutic drugs such as cisplatin [22] and gefitinib [23]. The gene discussed is CCND1; the disease is head and neck squamous cell carcinoma.